US OptionsDetailed Quotes
VKTX241129C80000
- 0.13
- +0.08+160.00%
15min DelayClose Nov 27 16:00 ET
0.13High0.13Low
0.13Open0.05Pre Close21 Volume446 Open Interest80.00Strike Price273.00Turnover300.37%IV47.00%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.0329Delta0.0068Gamma419.31Leverage Ratio-0.1285Theta0.0001Rho13.80Eff Leverage0.0026Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet